(HYLB) Xtrackers USD High Yield - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US2330514322

High Yield Bonds, Corporate, Bonds

Description: HYLB Xtrackers USD High Yield

The Xtrackers USD High Yield Corporate Bond ETF (NYSE ARCA:HYLB) is an investment vehicle that focuses on high yield corporate bonds denominated in U.S. dollars, investing at least 80% of its net assets in this asset class. This ETF is designed to track an underlying index that is concentrated in the high yield corporate bond market.

As an investor in HYLB, its essential to understand that the funds investments will be concentrated in a particular industry or group of industries if the underlying index is similarly concentrated. This means that the ETFs performance may be closely tied to the performance of specific sectors or industries. With an AUM of $3.76 billion, HYLB has a significant presence in the market.

From a technical analysis perspective, HYLB is currently trading at $36.34, with its short-term moving averages indicating a bullish trend. The SMA20 is at $36.19, and the SMA50 is at $35.70, both of which are below the current price, suggesting a potential upward momentum. However, the ETF is facing resistance at $36.4, and a break above this level could lead to further gains. On the downside, there are support levels at $35.9, $35.3, $34.7, and $34.1, which could provide a cushion in case of a decline.

Based on the technical and fundamental data, a potential forecast for HYLB is that it may continue to trade within a narrow range, potentially breaking above the resistance level of $36.4 if the high yield corporate bond market continues to perform well. However, if theres a downturn in the market, HYLB may decline towards its support levels. With the current yield environment and the ETFs focus on high yield corporate bonds, HYLB may remain an attractive option for investors seeking income-generating assets. A potential price target for HYLB could be around $37.0, representing a 2% increase from current levels, assuming the bullish trend continues.

Additional Sources for HYLB ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

HYLB ETF Overview

Market Cap in USD 3,852m
Category High Yield Bond
TER 0.05%
IPO / Inception 2016-12-06

HYLB ETF Ratings

Growth Rating 55.9
Fundamental -
Dividend Rating 67.3
Rel. Strength 8.84
Analysts -
Fair Price Momentum 37.30 USD
Fair Price DCF -

HYLB Dividends

Dividend Yield 12m 5.86%
Yield on Cost 5y 7.40%
Annual Growth 5y 1.70%
Payout Consistency 85.7%
Payout Ratio %

HYLB Growth Ratios

Growth Correlation 3m 95.6%
Growth Correlation 12m 88.2%
Growth Correlation 5y 57.6%
CAGR 5y 5.24%
CAGR/Max DD 5y 0.34
Sharpe Ratio 12m 1.68
Alpha 4.69
Beta 0.190
Volatility 4.75%
Current Volume 969.5k
Average Volume 20d 794.6k
What is the price of HYLB shares?
As of July 01, 2025, the stock is trading at USD 36.92 with a total of 969,509 shares traded.
Over the past week, the price has changed by +0.79%, over one month by +1.82%, over three months by +3.75% and over the past year by +10.99%.
Is Xtrackers USD High Yield a good stock to buy?
Partly, yes. Based on ValueRay´s Analyses, Xtrackers USD High Yield (NYSE ARCA:HYLB) is currently (July 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 55.87 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of HYLB is around 37.30 USD . This means that HYLB is currently overvalued and has a potential downside of 1.03%.
Is HYLB a buy, sell or hold?
Xtrackers USD High Yield has no consensus analysts rating.
What are the forecasts for HYLB share price target?
According to our own proprietary Forecast Model, HYLB Xtrackers USD High Yield will be worth about 40.7 in July 2026. The stock is currently trading at 36.92. This means that the stock has a potential upside of +10.16%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 40.7 10.2%